May 2, 2024, 10:41
Myeloma Paper of the Day, May 1st, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day: Study of ubiquitin-specific protease 7 inhibitors reveals a different mechanism of action vs. MDM2 inhibitors and shows anti-cancer activity in pre-clinical in vitro and in vivo models of myeloma.”
Proceed to the article.
Source: Robert Orlowski/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19